alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
PGI PART 15 – CONTRACTING BY NEGOTIATION       PGI SUBPART 15.4 – CONTRACT PRICING                                                         PGI 15.403-3 Requiring data other than certified cost or pricing data.    PGI SUBPART 15.4 – CONTRACT PRICING     PGI 15.403-3 Requiring data other than certified cost or pricing         data.     (6)(ii) Instead of forwarding information directly to Defense Pricing and Contracting **(**DPC), HCAs shall submit consolidated, validated reports to the DLA Acquisition Compliance, Policy and Pricing Division Pricing Program Manager (PM) within 20 days after the end of each quarter. Negative replies are required. The DLA Acquisition Compliance, Policy and Pricing Division Pricing PM will consolidate all submitted reports and forward the DLA report to DPC. When the DLA Acquisition Deputy Director is the HCA, contracting officers shall submit reports through the contracting chain of command, in accordance with procedures established by the contracting office, to the DLA Acquisition Compliance, Policy and Pricing Division Pricing PM, who will brief the DLA Acquisition Deputy Director. Submit reports using the spreadsheet at Denials of Requests for Data Other than Certified Cost or Pricing Data) https://dlamil.dps.mil/sites/Acquisition/Shared%20Documents/J-72/4_%20Attachment_A-2_Denied_Data_Requests_Template_with_2-Added_Columns.xlsx).
Exhibit 31.1
 
 Control Certification:
 
 
 I, Gary D. Engle, certify that:
 
 1.  I have reviewed this annual report on Form 10-KSB of Semele Group Inc;
 
 2.  Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
 
 3.  Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
 
 4.  The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14 for the registrant and have:
 
 a)  designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
 
 b)  evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the Evaluation Date); and
 
 c)  presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;
 
 5.  The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):
 
 d)  all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and
 
 e)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and
 
 6.  The registrants other certifying officer and I have indicated in this annual report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
 
 /s/ Gary D. Engle
 Gary D. Engle
 Chairman and Chief Executive Officer
 (Principal Executive Officer)
 August 23, 2004
#### UNITED STATES of America, Plaintiff-Appellant, v. Jorge ARROYO, a/k/a Sergio, Defendant-Appellee.

No. 85-2605.

United States Court of Appeals, Fifth Circuit.

July 16, 1986.

Henry K. Oncken, U.S. Atty., Susan L. Yarbrough, James R. Gough, Asst. U.S. Attys., Houston, Tex., Gloria C. Phares, Washington, D.C., for plaintiff-appellant.

Don Lambright, Kent A. Schaffer, Houston, Tex., for defendant-appellee.

ON PETITION FOR REHEARING

Before GEE, RANDALL, and DAVIS, Circuit Judges.

PER CURIAM:

IT IS ORDERED that the petition for rehearing filed by the appellee in the above entitled and numbered cause be and the same is hereby GRANTED. Our earlier opinion is withdrawn, and the appeal is reinstated on the Oral Argument calendar of the Court.
EX-31 Rule 13a-14(d)/15d-14(d) Certifications.


I, Larry Kravetz, certify that:

1. I have reviewed this report on Form 10-K and all reports on Form 10-D
required to be filed in respect of the period covered by this report on
Form 10-K of the UBS-Barclays Commercial Mortgage Trust 2013-C6 (the "Exchange Act
periodic reports");

2. Based on my knowledge, the Exchange Act periodic reports, taken as a
whole, do not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;

3. Based on my knowledge, all of the distribution, servicing and other
information required to be provided under Form 10-D for the period covered
by this report is included in the Exchange Act periodic reports;

4. Based on my knowledge and the servicer compliance statements required in
this report under Item 1123 of Regulation AB, and except as disclosed in
the Exchange Act periodic reports, the servicers have fulfilled their
obligations under the servicing agreements in all material respects; and

5. All of the reports on assessment of compliance with servicing criteria for
asset-backed securities and their related attestation reports on assessment
of compliance with servicing criteria for asset-backed securities required
to be included in this report in accordance with Item 1122 of Regulation AB
and Exchange Act Rules 13a-18 and 15d-18 have been included as an exhibit to
this report, except as otherwise disclosed in this report. Any material
instances of noncompliance described in such reports have been disclosed in
this report on Form 10-K.

In giving the certifications above, I have reasonably relied on information
provided to me by the following unaffiliated parties:

Midland Loan Services, a Division of PNC Bank, National Association, as Master
Servicer, Rialto Capital Advisors, LLC, as Special Servicer, U.S. Bank National
Association, as Trustee, Certificate Administrator and Custodian, Park Bridge Lender
Services, LLC, as Operating Advisor, Midland Loan Services, a Division of PNC Bank,
National Association, as Primary Servicer for the Santa Anita Mall Mortgage Loan,
Midland Loan Services, a Division of PNC Bank, National Association, as Special
Servicer for the Santa Anita Mall Mortgage Loan, Deutsche Bank Trust Company Americas,
as Trustee, Certificate Administrator and Custodian for the Santa Anita Mall Mortgage
Loan, and Situs Holdings, LLC, as Operating Advisor for the Santa Anita Mall Mortgage
Loan.

Dated: March 30, 2015

/s/Larry Kravetz

Larry Kravetz
President
(senior officer in charge of securitization of the depositor)
#### § 1271.390 Applicability.

The provisions set forth in this subpart are applicable only to HCT/Ps described in § 1271.10 and regulated solely under section 361 of the Public Health Service Act and the regulations in this part, and to the establishments that manufacture those HCT/Ps. HCT/Ps that are drugs or devices regulated under the act, or are biological products regulated under section 351 of the Public Health Service Act, are not subject to the regulations set forth in this subpart.
§ 707.12 Specimen collection, handling and laboratory analysis for drug testing. ( a ) Procedures for providing urine specimens must allow individual privacy, unless there is reason to believe that a particular individual may alter or substitute the specimen to be provided. Contractors shall utilize a chain of custody procedure for maintaining control and accountability from point of collection to final disposition of specimens, and testing laboratories shall use appropriate cutoff levels in screening specimens to determine whether they are negative or positive for a specific drug, consistent with the HHS Mandatory Guidelines (see § 707.5(a)). The contractor shall ensure that only testing laboratories certified by the Department of Health and Human Services, are utilized.
( b ) ( 1 ) If the individual refuses to cooperate with the urine collection (e.g., refusal to provide a specimen, or to complete paperwork), then the collection site person shall inform the MRO and shall document the non-cooperation on the specimen chain of custody form. The MRO shall report the failure to cooperate to the appropriate management authority, who shall report to DOE if the individual holds an access authorization. Individuals so failing to cooperate shall be treated in all respects as if they had been tested and had been determined to have used an illegal drug. The contractor may apply additional sanctions consistent with its disciplinary policy.
( 2 ) The collection site person shall ascertain that there is a sufficient amount of urine to conduct an initial test, a confirmatory test, and a retest, in accordance with the HHS Mandatory Guidelines. If there is not a sufficient amount of urine, additional urine will be collected in a separate container. The individual may be given reasonable amounts of liquid and a reasonable amount of time in which to provide the specimen required. The individual and the collection site person must keep the specimen in view at all times. In the event that the individual fails to provide a sufficient amount of urine, the amount collected will be noted on the “Urine Sample Custody Document.” In this case, the collection site person will telephone the individual's supervisor who will determine the next appropriate action. This may include deciding to reschedule the individual for testing, to return the individual to his or her work site and initiate disciplinary action, or both.
[57 FR 32656, July 22, 1992, as amended at 73 FR 3863, Jan. 23, 2008; 80 FR 5008, Jan. 30, 2015]
Exhibit 10.3


AMENDMENT
TO

CHRISTOPHER & BANKS CORPORATION

2005 STOCK INCENTIVE PLAN


 


This Amendment to
Christopher & Banks Corporation 2005 Stock Incentive Plan (the “Plan”)
is hereby approved by the Christopher & Banks Corporation Board of
Directors to be effective on July 26, 2006.




WITNESSETH:


WHEREAS, on April 7,
2005, the Company’s Board of Directors initially approved the Plan; and


WHEREAS, the
Company’s Board of Directors wishes to amend Section 4.3 of the Plan
effective as of July 26, 2006, to avoid having the Company incur
substantial compensation costs.


NOW, THEREFORE, BE
IT RESOLVED that the Plan is hereby amended, as follows:


4.3           Adjustments. In the event of an increase or decrease in the
number of shares of Common Stock resulting from a stock dividend, stock split,
reverse split, combination or reclassification of the Common Stock, or any
other increase or decrease in the number of issued shares of Common Stock
effected without receipt of consideration by the Company, the number of shares
of Stock reserved under Section 4.1 hereof, the number of shares of Stock
covered by each outstanding Award and Option and the price per share thereof
shall be appropriately adjusted  to reflect
such change. Additional shares which may become covered by the Award or Option
pursuant to such adjustment shall be subject to the same restrictions as are
applicable to the shares with respect to which the adjustment relates.
<TABLE> <S> <C>


<ARTICLE>     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS IN FORM 10-Q FOR MEDIALINK WORLDWIDE INCORPORATED FOR THE
PERIOD ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>



<S>                                                <C>
<PERIOD-TYPE>                                       3-MOS
<FISCAL-YEAR-END>                                             DEC-31-2000
<PERIOD-START>                                                JAN-01-2000
<PERIOD-END>                                                  MAR-31-2000
<CASH>                                                          2,074,405
<SECURITIES>                                                            0
<RECEIVABLES>                                                  13,672,150
<ALLOWANCES>                                                      375,000
<INVENTORY>                                                             0
<CURRENT-ASSETS>                                               16,921,843
<PP&E>                                                          6,781,096
<DEPRECIATION>                                                  3,297,138
<TOTAL-ASSETS>                                                 35,707,688
<CURRENT-LIABILITIES>                                           5,054,829
<BONDS>                                                                 0
<PREFERRED-MANDATORY>                                                   0
<PREFERRED>                                                             0
<COMMON>                                                           56,713
<OTHER-SE>                                                     30,452,417
<TOTAL-LIABILITY-AND-EQUITY>                                   35,707,688
<SALES>                                                        13,416,861
<TOTAL-REVENUES>                                               13,416,861
<CGS>                                                           5,005,809
<TOTAL-COSTS>                                                   5,005,809
<OTHER-EXPENSES>                                                7,638,918
<LOSS-PROVISION>                                                        0
<INTEREST-EXPENSE>                                                  8,100
<INCOME-PRETAX>                                                   799,009
<INCOME-TAX>                                                      332,000
<INCOME-CONTINUING>                                               467,009
<DISCONTINUED>                                                          0
<EXTRAORDINARY>                                                         0
<CHANGES>                                                               0
<NET-INCOME>                                                      467,009
<EPS-BASIC>                                                          0.08
<EPS-DILUTED>                                                        0.08




</TABLE>
# m8777.docx

EUROPEAN COMMISSION Brussels, 12.2.2018 C(2018) 971 final To the Notifying parties Subject : Case M. 8777 - VOTORANTIM / CPPIB / VTRM ENERGIA PARTICIPACOES / VENTOS DO ARARIPE III Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 19 January 2018 , the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which the undertakings Votorantim (Brazil) and Canada Pension Plan Investment Board (CPPIB , Canada) , acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control over a newly created company constituting a joint venture VTRM Energia Participações S.A. (VTRM , Brazil) by way of purchase of shares . 3 As part of the proposed concentration, Votorantim and CPPIB will jointly acquire Ventos do Araripe III and will transfer its assets to VTRM. 2. The business activities of the undertakings concerned are: - for Votorantim : it is active in a variety of business segments including cement and concrete, mining and metallurgy (aluminium, steel, nickel and zinc), pulp and paper, concentrated orange juice, chemical specialty markets, self-generation of electric power and financial sector , - for CPPIB : it is a professional investment management organisation that invests the funds not needed by the Canada Pension Plan Fund (CPP Fund) . In order to build a diversified portfolio of assets, CPPIB invests in public equities, private equities, real estate, infrastructure and fixed income instruments , - for Ventos do Araripe III: operates wind farms in Brazil, - for VTRM : newly created JV which operates wind farms in Brazil . 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( a ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission
(Signed)
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 33 , 30.1.2018 , p. 21 .
(4)
OJ C 366, 14.12.2013, p. 5 .
#### § 133.109 Brick cheese for manufacturing.

Brick cheese for manufacturing conforms to the definition and standard of identity for brick cheese prescribed by § 133.108, except that the dairy ingredients are not pasteurized and curing is not required.

[54 FR 32053, Aug. 4, 1989]
§ 1316.21 Definitions. As used in this part, the following terms shall have the meanings specified: ( a ) The term *investigative personnel* includes managers, Diversion Investigators, attorneys, analysts and support personnel employed by the Drug Enforcement Administration who are involved in the processing, reviewing and analyzing of declarations and other relevant documents or data relative to regulated transactions or are involved in conducting investigations initiated pursuant to the receipt of such declarations, documents or data.
( b ) The term *law enforcement personnel* means Special Agents employed by the Drug Enforcement Administration who, in the course of their official duties, gain knowledge of information which is confidential under such section.
[54 FR 31670, Aug. 1, 1989]
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAR-26-2000
<PERIOD-START>                             MAR-29-1999
<PERIOD-END>                               JUN-27-1999
<CASH>                                             664
<SECURITIES>                                         0
<RECEIVABLES>                                    7,303
<ALLOWANCES>                                       272
<INVENTORY>                                      6,626
<CURRENT-ASSETS>                                14,980
<PP&E>                                          91,538
<DEPRECIATION>                                (84,412)
<TOTAL-ASSETS>                                  22,562
<CURRENT-LIABILITIES>                           16,931
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            35
<OTHER-SE>                                      72,681
<TOTAL-LIABILITY-AND-EQUITY>                    22,562
<SALES>                                         10,630
<TOTAL-REVENUES>                                10,630
<CGS>                                            8,063
<TOTAL-COSTS>                                    8,063
<OTHER-EXPENSES>                                 3,129
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 336
<INCOME-PRETAX>                                  (898)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (898)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (898)
<EPS-BASIC>                                   $(.27)
<EPS-DILUTED>                                   $(.27)


</TABLE>
<PAGE>   1
                                                                 EXHIBIT 11.01

                                HNC SOFTWARE INC.

                               STATEMENT REGARDING
                        COMPUTATION OF PER SHARE EARNINGS
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)



<TABLE>
<CAPTION>
                                                          YEAR ENDED DECEMBER 31,
                                                        1996       1995       1994
                                                       -------    -------    -------
<S>                                                    <C>        <C>        <C>
NET INCOME                                             $ 6,376    $ 2,123    $   548
                                                       =======    =======    =======

SHARES (1)
      Weighted average common shares outstanding        18,666     10,309      3,756


      Weighted average common stock options and
      warrants as determined by application of the
      treasury stock method (2)                          1,701      2,138      1,562


      Weighted average preferred shares outstanding
      assuming conversion to common stock (3)               --      4,454      8,552
                                                       -------    -------    -------


      Pro forma weighted average common and common
      equivalent shares outstanding                                16,901     13,870
                                                                  =======    =======


      Weighted average common and common
      equivalent shares outstanding                     20,367
                                                       =======


PRO FORMA NET INCOME PER SHARE OF COMMON STOCK                    $  0.13    $  0.04
                                                                  =======    =======

NET INCOME PER SHARE OF COMMON STOCK                   $  0.31
                                                       =======
</TABLE>




----------

(1)   All share and per share amounts have been adjusted to give retroactive
      effect to the stock split, which occurred on April 3, 1996.

(2)   Includes an adjustment for options pursuant to SAB No. 83 using the
      treasury stock method at the initial public offering price of $7.00 per
      share for all periods presented prior to or including the Company's public
      offering date of June 26, 1995.

(3)   All outstanding shares of the Company's preferred stock automatically
      converted into shares of common stock upon the consummation of the
      Company's initial public offering on June 26, 1995.